Page last updated: 2024-08-17

aspartic acid and tamoxifen

aspartic acid has been researched along with tamoxifen in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (11.76)	18.7374
1990's	4 (23.53)	18.2507
2000's	8 (47.06)	29.6817
2010's	2 (11.76)	24.3611
2020's	1 (5.88)	2.80

Authors

Authors	Studies
Bellman, K; Knegtel, RM; Settimo, L	1
Pawlicki, M; Zuchowska-Vogelgesang, B	1
Ehrlich, CE; Stehman, FB	1
O'Regan, MH; Phillis, JW; Song, D	1
Aschner, M; Kimelberg, HK; Rutledge, EM	1
Estevez, AY; O'Regan, MH; Phillis, JW; Song, D	1
Ochoa de la Paz, LD; Pasantes-Morales, H; Quesada, O; Sepúlveda, J	1
Arnold, DL; Caramanos, Z; Langleben, A; LeBlanc, R; Preul, MC; Shenouda, G; Villemure, JG	1
Bentrem, DJ; Jordan, VC; Liu, H; MacGregor Schafer, J; Zapf, JW	1
Jordan, VC; Liu, H; Pearce, ST	1
Feustel, PJ; Jin, Y; Kimelberg, HK	1
Anghel, SI; Auger, A; Croisetière, S; Dayan, G; Katzenellenbogen, JA; Lupien, M; Mader, S; Rocha, W	1
Camacho, A; Massieu, L; Montiel, T	1
Nakazawa, K; Ohwada, T; Oka, J; Saito, Y; Sato, K	1
Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG	1
Ben-Baruch, N; Brown, M; Dvir, A; Jeselsohn, R; Klein, B; Merenbakh-Lamin, K; Miller, VA; Rizel, S; Rubinek, T; Sarid, D; Soussan-Gutman, L; Wolf, I; Yeheskel, A; Yelensky, R	1
Katsumi, H; Morishita, M; Moroto, Y; Nomura, D; Ogawa, K; Yamamoto, A	1

Reviews

1 review(s) available for aspartic acid and tamoxifen

Article	Year
[New antineoplastic agents, their value and use]. Przeglad lekarski, 1982, Volume: 39, Issue:8 Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids	1982

Trials

1 trial(s) available for aspartic acid and tamoxifen

Article	Year
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma. Journal of neuro-oncology, 2008, Volume: 90, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease Progression; Female; Glioma; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Tamoxifen	2008

Other Studies

15 other study(ies) available for aspartic acid and tamoxifen

Article	Year
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Peritoneo-cystic shunt for malignant ascites. Gynecologic oncology, 1984, Volume: 18, Issue:3 Topics: Ascites; Aspartic Acid; Combined Modality Therapy; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Palliative Care; Peritoneum; Phosphonoacetic Acid; Suction; Tamoxifen; Urinary Bladder	1984
Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain research, 1998, Jan-12, Volume: 780, Issue:2 Topics: Animals; Aspartic Acid; Cerebral Cortex; Chloride Channels; Estrogen Antagonists; Glutamic Acid; Ischemic Attack, Transient; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Tamoxifen	1998
Pharmacological characterization of swelling-induced D-[3H]aspartate release from primary astrocyte cultures. The American journal of physiology, 1998, Volume: 274, Issue:6 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Triphosphate; Animals; Animals, Newborn; Aspartic Acid; Astrocytes; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Nitrobenzoates; Nucleotides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Tamoxifen; Temperature; Zidovudine	1998
Effects of anion channel blockers on hyposmotically induced amino acid release from the in vivo rat cerebral cortex. Neurochemical research, 1999, Volume: 24, Issue:3 Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amino Acids; Animals; Anions; Aspartic Acid; Cerebral Cortex; Ethanolamines; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hypotonic Solutions; Ion Channels; Male; Niflumic Acid; Rats; Rats, Sprague-Dawley; Sodium Chloride; Tamoxifen; Taurine	1999
Amino acids as osmolytes in the retina. Neurochemical research, 1999, Volume: 24, Issue:11 Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amino Acids; Animals; Aspartic Acid; Cell Size; Chickens; Chloride Channels; gamma-Aminobutyric Acid; Glutamic Acid; Nitrobenzoates; Osmolar Concentration; Osmosis; Potassium Chloride; Retina; Tamoxifen; Taurine	1999
Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. Neurosurgery, 2000, Volume: 46, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Dose-Response Relationship, Drug; Female; Glioblastoma; Humans; Lipid Metabolism; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Tamoxifen; Treatment Outcome; Tumor Stem Cell Assay	2000
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351. Cancer research, 2000, Sep-15, Volume: 60, Issue:18 Topics: Allosteric Regulation; Amino Acid Substitution; Aspartic Acid; Binding Sites; Drug Interactions; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Glycine; Humans; Kinetics; Ligands; Mutagenesis, Site-Directed; Protein Conformation; Protein Structure, Tertiary; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured	2000
Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12. The Journal of biological chemistry, 2003, Feb-28, Volume: 278, Issue:9 Topics: Aspartic Acid; Blotting, Northern; Blotting, Western; Cell Line; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Humans; Ligands; Luciferases; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Time Factors; Transcription, Genetic; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured	2003
Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke, 2004, Volume: 35, Issue:5 Topics: Amino Acid Transport System X-AG; Animals; Anion Transport Proteins; Aspartic Acid; Astrocytes; Brain Ischemia; Cerebral Cortex; Excitatory Amino Acids; Glutamic Acid; Infarction, Middle Cerebral Artery; Kainic Acid; Microdialysis; Neurons; Rats; Receptors, Glutamate; Tamoxifen; Taurine	2004
Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha. Molecular pharmacology, 2006, Volume: 70, Issue:2 Topics: Aspartic Acid; Cell Line; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen	2006
The anion channel blocker, 4,4'-dinitrostilbene-2,2'-disulfonic acid prevents neuronal death and excitatory amino acid release during glycolysis inhibition in the hippocampus in vivo. Neuroscience, 2006, Nov-03, Volume: 142, Issue:4 Topics: Animals; Aspartic Acid; Brain Ischemia; Cell Death; Energy Metabolism; Excitatory Amino Acids; Exocytosis; Extracellular Fluid; Glycolysis; Hippocampus; Male; Microdialysis; Nerve Degeneration; Nitrobenzoates; Phloretin; Rats; Rats, Wistar; Riluzole; Stilbenes; Tamoxifen; Vesicular Glutamate Transport Proteins; Voltage-Dependent Anion Channels	2006
Effects of tamoxifen on L-glutamate transporters of astrocytes. Journal of pharmacological sciences, 2008, Volume: 107, Issue:2 Topics: Amino Acid Transport System X-AG; Animals; Aspartic Acid; Astrocytes; Cells, Cultured; Dose-Response Relationship, Drug; Estrogen Antagonists; Glutamic Acid; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Receptors, Estrogen; Tacrine; Tamoxifen	2008
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer. Cancer research, 2013, Dec-01, Volume: 73, Issue:23 Topics: Amino Acid Substitution; Antineoplastic Agents, Hormonal; Aspartic Acid; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Glycine; Humans; MCF-7 Cells; Mutation, Missense; Tamoxifen	2013
A Dense Layer of Polyethyleneglycol and Zwitterionic Bone Targeting Peptide on the Surface of Stereocomplex Polylactide-Polyethyleneglycol Nanoparticles Improves Shelf-storage Stability and the Serum Compatibility. Journal of pharmaceutical sciences, 2022, Volume: 111, Issue:10 Topics: Animals; Aspartic Acid; Cysteine; Hydroxyapatites; Lysine; Mice; Nanoparticles; Peptides; Polyesters; Polyethylene Glycols; Protein Corona; Tamoxifen	2022